国邦医药
(605507)
| 流通市值：142.86亿 | | | 总市值：142.86亿 |
| 流通股本：7.82亿 | | | 总股本：7.82亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 3,142,428,542.07 | 1,520,880,277.95 | 6,011,397,499.1 | 4,469,884,398.26 |
| 营业总成本 | 2,771,333,618.87 | 1,334,911,518.48 | 5,101,191,544.3 | 3,740,282,795.29 |
| 其他经营收益 | | | | |
| 营业利润 | 390,710,305.92 | 187,940,079.79 | 963,993,951.63 | 779,438,726 |
| 利润总额 | 387,837,408.67 | 187,173,418.77 | 951,259,911.75 | 774,877,685.03 |
| 净利润 | 341,322,474.13 | 160,128,633.56 | 817,573,712.5 | 667,887,425.77 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 341,322,474.13 | 160,128,633.56 | 817,573,712.5 | 667,887,425.77 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 6,470,751,666.11 | 6,531,692,348.03 | 6,112,848,808.72 | 5,752,197,720.14 |
| 非流动资产: | | | | |
| 非流动资产合计 | 4,912,567,707.74 | 4,864,102,587.55 | 4,871,786,859.23 | 4,827,185,118.83 |
| 资产总计 | 11,383,319,373.85 | 11,395,794,935.58 | 10,984,635,667.95 | 10,579,382,838.97 |
| 流动负债: | | | | |
| 流动负债合计 | 2,774,807,004.43 | 2,571,091,409.77 | 1,921,262,333.75 | 1,796,077,779.64 |
| 非流动负债: | | | | |
| 非流动负债合计 | 206,833,793.22 | 109,018,372.18 | 507,816,814.13 | 508,029,694.74 |
| 负债合计 | 2,981,640,797.65 | 2,680,109,781.95 | 2,429,079,147.88 | 2,304,107,474.38 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 8,399,271,382.99 | 8,713,753,411.68 | 8,553,123,737 | 8,271,649,874.93 |
| 股东权益合计 | 8,401,678,576.2 | 8,715,685,153.63 | 8,555,556,520.07 | 8,275,275,364.59 |
| 负债和股东权益合计 | 11,383,319,373.85 | 11,395,794,935.58 | 10,984,635,667.95 | 10,579,382,838.97 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,686,365,864 | 1,144,813,298.98 | 4,780,269,295.43 | 3,744,040,619.72 |
| 经营活动现金流出小计 | 2,231,416,330.29 | 951,636,776.9 | 4,220,991,135.85 | 3,338,530,251.02 |
| 经营活动产生的现金流量净额 | 454,949,533.71 | 193,176,522.08 | 559,278,159.58 | 405,510,368.7 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 6,552,703,272.86 | 3,383,229,932.46 | 15,392,841,002.9 | 11,235,187,266.33 |
| 投资活动现金流出小计 | 6,703,419,647.11 | 3,476,488,235.6 | 16,244,299,904.44 | 11,747,605,860.93 |
| 投资活动产生的现金流量净额 | -150,716,374.25 | -93,258,303.14 | -851,458,901.54 | -512,418,594.6 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 485,000,000 | 325,000,000 | 1,216,605,958.45 | 912,045,385.23 |
| 筹资活动现金流出小计 | 905,214,087.28 | 278,906,260.44 | 1,339,553,954.51 | 1,187,167,685.77 |
| 筹资活动产生的现金流量净额 | -420,214,087.28 | 46,093,739.56 | -122,947,996.06 | -275,122,300.54 |
| 汇率变动对现金及现金等价物的影响 | -18,995,565.99 | -7,741,059.84 | -1,358,562.08 | 3,233,366.23 |
| 现金及现金等价物净增加额 | -134,976,493.81 | 138,270,898.66 | -416,487,300.1 | -378,797,160.21 |
| 期末现金及现金等价物余额 | 982,907,769.93 | 1,256,155,162.4 | 1,117,884,263.74 | 1,155,574,403.63 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -134,976,493.81 | - | -416,487,300.1 | - |
最新报告期：2026-09-07| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 浙商证券 | 盖文化,郭双喜 | 1.08 | 1.31 | 1.55 | 2026-09-07 |
| 招商证券 | 侯彪,梁广楷,许菲菲 | 1.22 | 1.61 | 1.86 | 2026-08-25 |
| 开源证券 | 阮帅,余汝意 | 1.13 | 1.44 | 1.87 | 2026-08-04 |